lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
822 rows where filing_year = 2011 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1070772 | CLAUDIA SCHLOSBERG 8489645a-77a6-4180-98bd-e8a17e5b97de | 1T | CLAUDIA SCHLOSBERG | 318130 | COVENANT PHARMACY, LLC | 2011 | first_quarter | PHA | Controlled Substances Act | SENATE | 0 | 1 | 2011-03-30T14:52:12.003000-04:00 | ||
| 1070776 | CLAUDIA SCHLOSBERG 9161a140-348e-4d10-8bfc-d15e47a74997 | 1T | CLAUDIA SCHLOSBERG | 318130 | FORUM EXTENDED CARE SERVICES | 2011 | first_quarter | PHA | Controlled Substances Act | SENATE | 0 | 1 | 2011-03-30T15:14:15.837000-04:00 | ||
| 1070778 | CLAUDIA SCHLOSBERG b07ff490-2a7a-46b0-859e-aaa69f8a2164 | 1T | CLAUDIA SCHLOSBERG | 318130 | MCNEILL'S LONG TERM CARE PHARMACY | 2011 | first_quarter | PHA | Controlled Substances Act | SENATE | 0 | 1 | 2011-03-30T15:20:18.120000-04:00 | ||
| 1070781 | CLAUDIA SCHLOSBERG 1d6d570a-0b9a-4761-893c-9a40899e847d | 1T | CLAUDIA SCHLOSBERG | 318130 | PHARMACY CARE ASSOCIATES | 2011 | first_quarter | PHA | Controlled Substances Act | SENATE | 0 | 1 | 2011-03-30T15:26:20.437000-04:00 | ||
| 1070840 | HOLLAND & KNIGHT LLP 2a5467c0-682e-42ca-934c-76830b9821f9 | Q1 | HOLLAND & KNIGHT LLP | 18466 | AMERICAN SOCIETY OF HEMATOLOGY | 2011 | first_quarter | PHA | Hematology and Oncology drug research and approval issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2011-03-31T12:10:22.433000-04:00 | |
| 1070850 | HOLLAND & KNIGHT LLP c6b1bb39-0052-4adf-937a-7634680fc959 | Q1 | HOLLAND & KNIGHT LLP | 18466 | NATIONAL HEMOPHILIA FOUNDATION | 2011 | first_quarter | PHA | Blood and blood product safety; issues related to blood product approvals; Blood donor deferral policies, 340B Drug purchasing program and orphan drugs. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 40000 | 0 | 0 | 2011-03-31T12:14:25.840000-04:00 | |
| 1070912 | RED+BLUE STRATEGIES 6e10da1b-1960-4be0-94be-8bb074f3b01d | Q1 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2011 | first_quarter | PHA | Medicare and Medicaid regulations and guidance specific to drug pricing | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-04-01T12:30:20.533000-04:00 | |
| 1070955 | PUBLIC AFFAIRS RESOURCES, INC. 273d59ab-481c-4b57-b879-25f26ee2590c | Q1 | PUBLIC AFFAIRS RESOURCES, INC. | 31270 | PACKAGING CORPORATION OF AMERICA (PCA) (BOISE INC IS NOW A SUBSIDIARY OF PCA ) | 2011 | first_quarter | PHA | Electronic Professional Inserts in lieu of Paper, FDA | Federal Reserve System,HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-01T15:40:47.960000-04:00 | |
| 1071000 | CYBER SECURITY RESEARCH CONSULTANTS, LLC 6e44d05b-62da-4af4-b067-92433b306596 | Q1 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2011 | first_quarter | PHA | Food and Drug Safety Globalization Act Moniitoring Dorgan-Snowe Drug Reimportation from Canada Health Care Reform | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-03T15:42:37.207000-04:00 | |
| 1071172 | LONG TERM CARE PHARMACY ALLIANCE 2b0f56e5-3af7-4cbc-91ca-aa21be5b5f53 | Q1 | LONG TERM CARE PHARMACY ALLIANCE | 400309443 | LONG TERM CARE PHARMACY ALLIANCE | 2011 | first_quarter | PHA | Medicare Part D | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 201000 | 0 | 0 | 2011-04-04T14:25:48.210000-04:00 | |
| 1071275 | RED+BLUE STRATEGIES 06bbb87b-7249-41a7-892d-9c1d977f7cf6 | Q1 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2011 | first_quarter | PHA | Issues regarding a newly approved drug, Makena, by the FDA. | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-04-05T11:07:06.350000-04:00 | |
| 1071458 | DUQUESNE UNIVERSITY f68b3c69-cd88-459f-8b40-8099e643991a | Q1 | DUQUESNE UNIVERSITY | 400535603 | DUQUESNE UNIVERSITY | 2011 | first_quarter | PHA | On March 31, 2011 meetings on Capitol Hill took place to discuss Duquesne University's School of Pharmacy and its various community outreach activities including the School's application to join HRSA's 340B drug pricing program, and application for a FQHC Planning Grant. Senator Casey's office agreed to send a letter of support to HRSA in support of the FQHC Planning Grant application. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-04-06T11:00:23.663000-04:00 | ||
| 1071683 | AMERICAN COLLEGE OF CLINICAL PHARMACY 9e2450c9-3ed9-4a74-93a0-f2f3fe0e47ea | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2011 | first_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 59600 | 0 | 0 | 2011-04-06T15:37:20.920000-04:00 | |
| 1071718 | RED+BLUE STRATEGIES 0231e8ab-bb14-42e0-831d-dd51e0058c41 | Q1 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2011 | first_quarter | PHA | Issues related to upstream and downstream drug supply chain safety. Working to help develop both legislative and non-legislative movement around issues related to the development of new generations of antibiotics (bills have not yet been introduced). | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2011-04-06T16:55:40.687000-04:00 | |
| 1072098 | INDEPENDENT PHARMACY COOPERATIVE a283f822-b3bb-4959-84ff-7175a64a8083 | Q1 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2011 | first_quarter | PHA | Short-Cycle dispensing of medication in long-term care facilities. CMS Proposed Rule. All provisions DEA Physician/Nurse Agent Definition. H.R. 891 The Medication Therapy Management Benefits Act of 2011. All provisions. S. 274 TheMedication Management Empowerment Act of 2011. All provisions | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-04-08T11:15:35.153000-04:00 | |
| 1072327 | PARRY, ROMANI, DECONCINI & SYMMS 1d5e90af-22f6-4352-8142-09cbad6a0fa9 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2011 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-04-08T15:22:26.917000-04:00 | |
| 1072369 | PARRY, ROMANI, DECONCINI & SYMMS ea00aa64-6bd2-400b-bbc9-3978c2947303 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2011 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2011-04-08T15:42:43.937000-04:00 | |
| 1072651 | RUBICON ADVISORS, LLC eaaf0be6-372b-489e-ae04-0cba51abeece | Q1 | RUBICON ADVISORS, LLC | 315091 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2011 | first_quarter | PHA | Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-11T11:08:20.853000-04:00 | |
| 1072652 | RUBICON ADVISORS, LLC 44932da4-ab64-4cfe-b072-793dae6d152a | Q1 | RUBICON ADVISORS, LLC | 315091 | CHILDREN'S HOSPITAL AND RESEARCH CENTER | 2011 | first_quarter | PHA | Health Care | HOUSE OF REPRESENTATIVES,SENATE | 37500 | 0 | 0 | 2011-04-11T11:10:21.600000-04:00 | |
| 1072668 | RUBICON ADVISORS, LLC 5a40fb18-6f05-4ca9-a2b9-ed7b5d976583 | Q1 | RUBICON ADVISORS, LLC | 315091 | GILEAD SCIENCES | 2011 | first_quarter | PHA | H.R. 822, H.R. 1943, H.R. 6114, S-2969 | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2011-04-11T11:22:30.203000-04:00 | |
| 1072669 | RUBICON ADVISORS, LLC 309f72d4-b02c-4a8a-979c-decf35ffe032 | Q1 | RUBICON ADVISORS, LLC | 315091 | INSMED INCORPORATED | 2011 | first_quarter | PHA | Generic Biologics S. 1695 Affordable Health Care Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 22500 | 0 | 0 | 2011-04-11T11:24:31.547000-04:00 | |
| 1072672 | RUBICON ADVISORS, LLC fe409a2d-80ab-4f03-8a14-73251b13a21b | Q1 | RUBICON ADVISORS, LLC | 315091 | OSMOTICA PHARMACEUTICALS | 2011 | first_quarter | PHA | FDA Citizen Petition Reform Affordable Healthcare Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 35000 | 0 | 0 | 2011-04-11T11:27:33.203000-04:00 | |
| 1072676 | RUBICON ADVISORS, LLC 70a31b4b-e6f6-43b3-9c5b-858f843e842f | Q1 | RUBICON ADVISORS, LLC | 315091 | TEVA PHARMACEUTICALS USA | 2011 | first_quarter | PHA | Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 105000 | 0 | 0 | 2011-04-11T11:29:34.903000-04:00 | |
| 1072677 | RUBICON ADVISORS, LLC d3eb2a2d-05ef-4cf5-92db-8baff7a4e93e | Q1 | RUBICON ADVISORS, LLC | 315091 | WATSON PHARMACEUTICALS INC | 2011 | first_quarter | PHA | Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 | HOUSE OF REPRESENTATIVES,SENATE | 98000 | 0 | 0 | 2011-04-11T11:31:35.653000-04:00 | |
| 1073072 | PARRY, ROMANI, DECONCINI & SYMMS ad6c9940-589e-4b04-bf56-340f4b6859e3 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2011 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-04-11T17:00:42.850000-04:00 | |
| 1073088 | PARRY, ROMANI, DECONCINI & SYMMS 4e1ae626-592c-4b9b-a1c8-114ed5a5372d | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2011 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. | HOUSE OF REPRESENTATIVES,SENATE | 11508 | 0 | 0 | 2011-04-11T17:13:52.467000-04:00 | |
| 1073102 | PARRY, ROMANI, DECONCINI & SYMMS b5c58240-d691-49bb-aced-f39da99456b5 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2011 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-04-11T17:24:59.107000-04:00 | |
| 1073390 | WHITMER & WORRALL, LLC d7542f8c-9973-49d6-8048-a588509a2220 | Q1 | WHITMER & WORRALL, LLC | 292892 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2011 | first_quarter | PHA | Issues related to monitoring healthcare reform. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-12T11:12:24.323000-04:00 | |
| 1073736 | POLICY DIRECTIONS INC. dd48e01b-1ad2-4e80-82a8-ff8914bf619a | Q1 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2011 | first_quarter | PHA | Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. Efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-12T15:06:37.427000-04:00 | |
| 1073892 | PD FRAZER CONSULTING, INC. 47fe36d7-8e2e-4134-a82e-150a5be2a457 | Q1 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2011 | first_quarter | PHA | Monitor the development of proposed bills about the importation of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-04-12T15:52:03.213000-04:00 | |
| 1074018 | THE RUSSELL GROUP, INC. d3b965b1-a080-4f90-a53c-a5256973bd58 | Q1 | THE RUSSELL GROUP, INC. | 22688 | GENERIC PHARMACEUTICAL ASSOCIATION | 2011 | first_quarter | PHA | Issues relative to generic pharmaceuticals and generic biologics; FY 2011 and FY 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); funding FDA Office of Generic Drugs; H.R. 1249, S. 23 - America Invents Act (2011). | HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 40000 | 0 | 0 | 2011-04-12T17:20:17.393000-04:00 | |
| 1074209 | UPS (UNITED PARCEL SERVICE) f88c4d40-112b-4747-9cb3-441c812c2f5e | Q1 | UPS (UNITED PARCEL SERVICE) | 39223 | UPS (UNITED PARCEL SERVICE) | 2011 | first_quarter | PHA | - Pedigree Track and Trace - HHS/CDC PEPFAR Grant for Supply | Commerce, Dept of (DOC),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR) | 1572401 | 0 | 0 | 2011-04-13T10:28:07.153000-04:00 | |
| 1074440 | THE MATHIS HARPLE GROUP 2d34eecc-1125-4f59-9af7-33e0077741c3 | Q1 | THE MATHIS HARPLE GROUP | 322911 | PILMA | 2011 | first_quarter | PHA | Health Care legislation | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-04-13T12:47:14.983000-04:00 | |
| 1075041 | GOVBIZ ADVANTAGE, INC. 0b77fcdf-fc0d-4d57-98fd-86157a276aaf | Q1 | GOVBIZ ADVANTAGE, INC. | 294234 | CATALYST HEALTH SOLUTIONS (CATAMARANRX) | 2011 | first_quarter | PHA | Pharmacy Benefit Issues in health legislation; PBA issues; General company congressional relations; business issues | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-13T17:44:06.733000-04:00 | |
| 1075414 | MEREDITH MCGEHEE c61871d8-5cbc-4a46-8a98-ff18bd02c489 | Q1 | MEREDITH MCGEHEE | 79858 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2011 | first_quarter | PHA | Funding for programs to develop AIDS vaccines targeted toward the developing world; Working with Global Health Technologies Coalition to educate on research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR and appropriations for USAID R&D and funding for IAVI; Provide information on IAVI's model; Providing input of foreign assistance reform from a global health perspective; funding and budget issues as related to USAID. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-14T10:46:06.453000-04:00 | |
| 1075509 | MCDERMOTT WILL & SCHULTE LLP 3742efae-1c2c-4863-bdb4-a9a3cf36a934 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ISIS PHARMACEUTICALS | 2011 | first_quarter | PHA | Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-14T11:17:24.677000-04:00 | |
| 1075635 | BUCHANAN INGERSOLL & ROONEY PC 04856c1a-4e24-4710-84ee-d1bb31393fb6 | Q1 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | SHIRE PHARMACEUTICALS INC | 2011 | first_quarter | PHA | Life Sciences investment Act; Creating Hope Act; Pharma fees and orphan drug exclusion; ESRD bundling of non-injectable oral equivalents, ESRD Quality Incentive program; orphan drugs; health care reform implementation; ADHD awareness | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-04-14T11:49:18.457000-04:00 | |
| 1076191 | DUTKO WORLDWIDE, LLC 46566eca-56f1-4d4a-ba4a-30cb72738262 | Q1 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2011 | first_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-14T15:35:24.010000-04:00 | |
| 1076590 | WINBORN SOLUTIONS LLC 3a4c38cd-7dc2-47b7-aac1-33e314ae13d5 | Q1 | WINBORN SOLUTIONS LLC | 308310 | PERRIGO CO | 2011 | first_quarter | PHA | Generic drug user fee legislation | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2011-04-14T20:22:13.263000-04:00 | |
| 1076639 | AMERICA'S ESSENTIAL HOSPITALS 88a8c366-5c33-4ea0-9345-c76beb31187e | Q1 | AMERICA'S ESSENTIAL HOSPITALS | 27057 | AMERICA'S ESSENTIAL HOSPITALS | 2011 | first_quarter | PHA | Request that stakeholders be permitted to review and comment on (i) Notice Regarding Section 602 of the Veterans Health Care Act of 1992 Definition of "Patient" (RIN: 0906-ZA08) and (ii) Notice Regarding Section 602 of the Veterans Health Care Act of 1992 Definition of "Patient" - Withdrawl of Previous Notice (RIN: 0906-ZA09) | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 190000 | 0 | 0 | 2011-04-15T09:11:46.180000-04:00 | |
| 1076755 | MCDERMOTT WILL & SCHULTE LLP 4e788be5-d061-4e93-9728-8aee0af040ea | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2011 | first_quarter | PHA | Issues related to Section 340B of the Public Health Service Act. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-04-15T10:28:49.257000-04:00 | |
| 1076851 | MCDERMOTT WILL & SCHULTE LLP dca9390b-6c6f-40b6-a274-e037ca5243b8 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2011 | first_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-15T11:11:43.990000-04:00 | |
| 1077190 | HANCE SCARBOROUGH 328ad9e4-23e5-42d1-895e-c9a4ed2527d7 | Q1 | HANCE SCARBOROUGH | 17443 | INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) | 2011 | first_quarter | PHA | Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-04-15T13:25:28.713000-04:00 | |
| 1077213 | HANCE SCARBOROUGH c6c112e7-90e9-46e2-8697-4b1797d1faf0 | Q1 | HANCE SCARBOROUGH | 17443 | TEXAS ACADEMY OF COMPOUNDING PHARMACISTS | 2011 | first_quarter | PHA | Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-04-15T13:33:42.913000-04:00 | |
| 1077332 | EVERTZ GROUP LLC b6901ea7-c12e-4feb-9e18-bb660109c71f | Q1 | EVERTZ GROUP LLC | 400497446 | MYLAN INC. | 2011 | first_quarter | PHA | Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. | Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) | 30000 | 0 | 0 | 2011-04-15T14:24:49.220000-04:00 | |
| 1077430 | AARP 7105b1a3-761e-4e04-ac2b-684601fedec3 | Q1 | AARP | 1694 | AARP | 2011 | first_quarter | PHA | H.J. Res. 44, H.J. 48, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed importance of potential savings to consumers through safe importation of prescription drugs and endorsed legislation. Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. | Administration on Aging,Agriculture, Dept of (USDA),Bureau of the Census,Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Energy Regulatory Commission (FERC),Federal Reserve System,Federal Transit Administration (FTA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Highway Traffic Safety Administration (NHTSA),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office | 5000000 | 0 | 0 | 2011-04-15T14:49:02.477000-04:00 | |
| 1077609 | WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC 49b1d5b7-e605-4690-af58-04b909197e2d | Q1 | WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC | 41113 | JARROW FORMULAS, INC. | 2011 | first_quarter | PHA | Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius; and the Dietary Supplement Health and Education Act | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-15T15:16:34.697000-04:00 | |
| 1077808 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 44d79e57-d2f7-4609-a9ce-ed20d5c9f3ad | Q1 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2011 | first_quarter | PHA | Importation of prescription drugs (S.319, H.R. 147); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation; NASPER Reauthorization (H.R. 866); Pill Mill Crackdown Act (H.R. 1065); Drug Abuse (S. 507); Drug Shortages (S. 296) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 232000 | 0 | 0 | 2011-04-15T15:48:14.107000-04:00 | |
| 1078139 | BGR GOVERNMENT AFFAIRS c05088c1-46ba-4373-a93e-57df0e85b194 | Q1 | BGR GOVERNMENT AFFAIRS | 5357 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2011 | first_quarter | PHA | Counsel and guidance on legislative or regulatory activity that could affect the pharmaceutical industry | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-15T17:28:07.783000-04:00 | |
| 1078390 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC a73dcd48-f20e-4706-8ea2-df87739e4722 | Q1 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC | 400689052 | WOCKHARDT USA LLC | 2011 | first_quarter | PHA | Preemption for ANDA holders under FDA Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-16T08:29:12.280000-04:00 | |
| 1078394 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 0636085b-3f16-4746-92d8-8dbc964c0e66 | Q1 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC | 400689052 | TEVA PHARMACUETICALS USA | 2011 | first_quarter | PHA | Proposals to limit settlements between ANDA and NDA holders in Hatch-Waxman litigation | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-16T08:42:15.667000-04:00 | |
| 1078878 | THE OB-C GROUP, LLC 5bc24748-b37f-4c42-9207-1eb387c7f032 | Q1 | THE OB-C GROUP, LLC | 29802 | ELI LILLY | 2011 | first_quarter | PHA | No specific bill number: matters relating to pharmaceutical manufacturers. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-18T09:20:49.470000-04:00 | |
| 1079086 | NATIONAL RETIREE LEGISLATIVE NETWORK 23a8bf58-2f7b-4c96-ba87-42e125fe31b7 | Q1 | NATIONAL RETIREE LEGISLATIVE NETWORK | 400559672 | NATIONAL RETIREE LEGISLATIVE NETWORK | 2011 | first_quarter | PHA | Pharmaceutical costs. | HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE | 15000 | 0 | 0 | 2011-04-18T10:05:34.223000-04:00 | |
| 1079558 | BLUECROSS BLUESHIELD OF TENNESSEE 3ead8ecb-ce5c-4ce1-bf22-dbe552994ab6 | Q1 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2011 | first_quarter | PHA | General Pharmacy Issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-04-18T11:12:39.557000-04:00 | |
| 1079703 | VENABLE LLP 4f76a6fb-7f82-4444-88b4-32dd962354e7 | Q1 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2011 | first_quarter | PHA | General issues affecting the pharmaceutical industry The Life Sciences Investment Act | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-04-18T11:35:56.630000-04:00 | |
| 1079727 | C2 GROUP, LLC d5465b61-6b33-4292-94ce-494edacdd023 | Q1 | C2 GROUP, LLC | 66693 | PERRIGO INC | 2011 | first_quarter | PHA | FSA Changes; Drug Regulation; FDA Reform; PDUFA | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-18T11:40:58.127000-04:00 | |
| 1080581 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 788cce9c-f954-4c3a-8812-3572c96d9bae | Q1 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 309377 | ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 2011 | first_quarter | PHA | Support legislation that would allow independent pharmacies to collectively negotiate contracts with prescription drug plans and health insurance plans. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-04-18T14:07:58.467000-04:00 | ||
| 1080603 | JULIE PHILP ab5a9ede-e3e2-4f2d-b518-cbd37b20830b | Q1 | JULIE PHILP | 400407928 | NATIONAL GRASSROOTS AND COMMUNICATION | 2011 | first_quarter | PHA | Support legislation that would allow independent pharmacies to collectively negotiate contracts with prescription drug plans and health insurance plans. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-04-18T14:11:13.650000-04:00 | |
| 1080631 | TARPLIN, DOWNS & YOUNG, LLC ffb5411d-3e85-42b7-8dd0-506010b70e26 | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2011 | first_quarter | PHA | **see addendum page Importation of prescription drugs (S.319/H.R. 147) Methamphetamine/Pseudoephedrine Regulation NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065) Drug Abuse (S. 507) Drug Stortages (S. 296) no specific bills, federal pedigree, import safety | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-04-18T14:13:27.433000-04:00 | |
| 1080636 | SMITH GARSON FKA SMITH DAWSON & ANDREWS 856f201e-1504-4141-a34c-7a6352cf0a67 | Q1 | SMITH GARSON FKA SMITH DAWSON & ANDREWS | 35707 | PROSETTA CORPORATION | 2011 | first_quarter | PHA | Government Advertisement of Biopharmaceuticals | 0 | 0 | 2011-04-18T14:13:30.230000-04:00 | |||
| 1080716 | SMITH GARSON FKA SMITH DAWSON & ANDREWS 16911756-b6ce-4b77-809d-24190202a373 | Q1 | SMITH GARSON FKA SMITH DAWSON & ANDREWS | 35707 | STRUVE SWINE TECHNOLOGIES | 2011 | first_quarter | PHA | Government Advertisement of Biopharmaceuticals | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-04-18T14:23:14.263000-04:00 | ||
| 1081056 | UNIVERSITY OF CONNECTICUT cc6e6c20-595d-4d3a-a3d2-eccb79d11fcf | Q1 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2011 | first_quarter | PHA | Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2012, FDA salaries and expenses; and extramural research related issues. HR1, Full-Year Continuing Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. | Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-04-18T14:56:32.593000-04:00 | |
| 1081159 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. efefa0b1-4c30-4404-bbd7-c38328bbb4a5 | Q1 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 4653 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 2011 | first_quarter | PHA | Proposals to require a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to change the requirements for the "major statement" in direct to consumer prescription drug advertisements | Commerce, Dept of (DOC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 260000 | 0 | 0 | 2011-04-18T15:08:33.107000-04:00 | |
| 1081585 | AKIN GUMP STRAUSS HAUER & FELD eb9f27fb-a362-479e-9f51-bb3acf22383f | Q1 | AKIN GUMP STRAUSS HAUER & FELD | 682 | PRASCO, INC. | 2011 | first_quarter | PHA | Promoting consumer benefits of authorizd generic drugs | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2011-04-18T16:06:24.873000-04:00 | |
| 1081824 | EMPIRE CONSULTING GROUP 6b82244c-5d23-4749-80da-698b874925ea | Q1 | EMPIRE CONSULTING GROUP | 400703105 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2011 | first_quarter | PHA | Diabetes education and awareness in minority communities; patent reform proposals | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2011-04-18T16:44:34.153000-04:00 | |
| 1081943 | MARSHFIELD CLINIC HEALTH SYSTEM 7a581052-325b-48b2-87d6-0dfe6930f376 | Q1 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2011 | first_quarter | PHA | Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA. | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE | 130000 | 0 | 0 | 2011-04-18T17:00:40.887000-04:00 | |
| 1082217 | EXPRESS SCRIPTS, INC. fbb7ec00-0a8c-40fe-8084-529214fdc79a | Q1 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2011 | first_quarter | PHA | Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (essential health benefits, grandfathering, value-base insurance design, Rx quality, electronic prescribing, PBM disclosure requirements, medical loss ratio); legislation to promote generic drugs; regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; Zadroga implement. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,White House Office | 490000 | 0 | 0 | 2011-04-18T17:38:58.027000-04:00 | |
| 1082296 | MR. MATTHEW R. SIMMONS 849163f3-1873-497e-9784-3a677f894be8 | Q1 | MR. MATTHEW R. SIMMONS | 400458211 | NATIONAL COALITION OF PHARMACEUTICAL DISTRIBUTORS | 2011 | first_quarter | PHA | PDMA reform; general pharmaceutical distribution policy | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-18T17:50:34.703000-04:00 | |
| 1082398 | TARPLIN, DOWNS & YOUNG, LLC 476ec097-db0f-44f5-9d8e-e09deb3c8474 | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | PHRMA | 2011 | first_quarter | PHA | **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act ***, no specific bill(s), prescription drug importation, import safety | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-04-18T18:06:20.087000-04:00 | |
| 1082425 | TARPLIN, DOWNS & YOUNG, LLC 193dc716-f4b7-4d09-b1ee-be8389cb5a0d | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2011 | first_quarter | PHA | **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-04-18T18:10:29.963000-04:00 | |
| 1082431 | TARPLIN, DOWNS & YOUNG, LLC d7195a97-4f91-4e0a-a7a0-52739b6094af | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | ASTRAZENECA | 2011 | first_quarter | PHA | **see addendum page **, no specific bill(s), Import Safety Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-18T18:12:33.480000-04:00 | |
| 1083330 | SQUIRE PATTON BOGGS b7c7c14a-31d7-4a90-b385-af9f1d04b954 | Q1 | SQUIRE PATTON BOGGS | 30906 | KV PHARMACEUTICAL COMPANY | 2011 | first_quarter | PHA | Prescription drug coverage and pricing for progesterone injection. | HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2011-04-19T09:12:32.317000-04:00 | |
| 1083536 | SQUIRE PATTON BOGGS dc2a868f-49a3-4222-a3bb-f112ac13eb01 | Q1 | SQUIRE PATTON BOGGS | 30906 | RANBAXY INC. | 2011 | first_quarter | PHA | S.27, Preserve Acess to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; H.R. 4, Comprehensive 1099 Taxpayer Protection and Repaymentof Exchange Subsidy Overpayments Act; S. 23, the America Invents Act; H.R. 1, Full Year Continuing Appropriations Act. | HOUSE OF REPRESENTATIVES,SENATE | 160000 | 0 | 0 | 2011-04-19T09:51:30.223000-04:00 | |
| 1084424 | LOCKE LORD PUBLIC POLICY GROUP LLC 582359fc-d2bf-4df5-a09e-feeeb829d159 | Q1 | LOCKE LORD PUBLIC POLICY GROUP LLC | 300971 | MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES | 2011 | first_quarter | PHA | Pharmaceutical performance reimbursement; biogenics | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-19T11:23:22.110000-04:00 | |
| 1084436 | POWERS PYLES SUTTER & VERVILLE, P.C. cffe4441-d18b-4365-8d6b-1a0cf214d8a7 | Q1 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | 340B HEALTH | 2011 | first_quarter | PHA | Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of children's hospitals to the 340B program, physician-administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement and Integrity Act of 2007 (S. 1376/H.R. 2606), Proposed guidelines from the Health Resources and Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Veterans Affairs, Dept of (VA) | 45000 | 0 | 0 | 2011-04-19T11:23:27.267000-04:00 | |
| 1084705 | ACADEMY OF MANAGED CARE PHARMACY 09c50b2b-2e32-43b1-81b9-0b03cbb8fc2c | Q1 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2011 | first_quarter | PHA | Legislation relating to pharmacy issues and the professional role of pharmacists, legislation relating to medication therapy management programs and funding for such programs, legislation relating to the importation of prescription drugs, legislation relating to settlement agreements between brand-name and generic manufacturers, legislation promoting the use of generic drugs generally, legislation relating to pharmacy benefit managers | HOUSE OF REPRESENTATIVES,SENATE | 178000 | 0 | 0 | 2011-04-19T11:49:42.250000-04:00 | |
| 1084881 | C2 GROUP, LLC 32b51b97-b75e-4a54-96dd-d2c56aae1c0d | 1A | C2 GROUP, LLC | 66693 | PERRIGO INC | 2011 | first_quarter | PHA | FSA Changes, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA Reform; PDUFA | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-19T12:07:23.500000-04:00 | |
| 1084898 | INDEPENDENCE BLUE CROSS 4827203c-da1c-45ea-81f0-891e1e6f276e | Q1 | INDEPENDENCE BLUE CROSS | 19172 | INDEPENDENCE BLUE CROSS | 2011 | first_quarter | PHA | FEHBP Pharmacy Benefits Contracting | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 0 | 0 | 2011-04-19T12:10:16.303000-04:00 | ||
| 1084986 | CAPITOL HILL CONSULTING GROUP a754da70-abb6-4e52-9a19-d220be00e871 | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2011 | first_quarter | PHA | Controlled Drug Substances Act (21 USC 13) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-19T12:22:06.247000-04:00 | |
| 1085122 | UNIVERSITY OF IOWA ad845130-52b9-4a16-b94e-19411b0e4add | Q1 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2011 | first_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 88684 | 0 | 0 | 2011-04-19T12:35:12.370000-04:00 | |
| 1085263 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS b2b6db64-e2a6-4c39-93ff-c5f016c40a59 | Q1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2011 | first_quarter | PHA | Communication to Surgeon General on recognition of pharmacists as health care providers. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 250000 | 0 | 0 | 2011-04-19T12:46:14.373000-04:00 | |
| 1085762 | AMERICAN PHARMACISTS ASSOCIATION 8ed6768a-c97a-47ae-a0ad-178359dd5b01 | Q1 | AMERICAN PHARMACISTS ASSOCIATION | 3071 | AMERICAN PHARMACISTS ASSOCIATION | 2011 | first_quarter | PHA | Pharmacist Loan Repayment Eligibility Act of 2011 (S.48) (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: FDA-2011-D-0074-0001) Draft Guidance for Industry on Medication Guides; Availability: Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies; Availability (Docket Number: FDA-2010-N-0633) Determination of System Attributes for Tracking and Tracing of Prescription Drugs; Public Workshop (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: FDA2011N0100) Drugs for Human Use; Unapproved and Misbranded Oral Drugs Labeled for Prescription Use and Offered for Relief of Symptoms of Cold, Cough, or Alergy; Enforcement Action Dates (Docket Number: FDA-2011-N-0002) Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee; Notice of Meeting Concept - Standardizing REMS programs, components and development of a potential tiered REMS System Concept - Designing Pilot Programs to Distribute Patient Medication Information Concept - Drug Disposal Concept - Preventing counterfeit prescription drugs from entering the supply chain | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 187231 | 0 | 0 | 2011-04-19T13:40:18.277000-04:00 | |
| 1086300 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES 69980c3b-4cb4-42d1-8495-2c628882d6e9 | Q1 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2011 | first_quarter | PHA | S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE | 660000 | 0 | 0 | 2011-04-19T14:31:48.917000-04:00 | |
| 1086351 | AMERICAN ADVERTISING FEDERATION 311af5b8-9068-4e72-9f20-72d6eb471e70 | Q1 | AMERICAN ADVERTISING FEDERATION | 1411 | AMERICAN ADVERTISING FEDERATION | 2011 | first_quarter | PHA | Proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals Proposals to require a moratorium on the advertising of new prescription medicines Proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs | Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 41000 | 0 | 0 | 2011-04-19T14:35:09.180000-04:00 | |
| 1086761 | WALGREEN COMPANY c63ee7a1-457d-4d63-90c3-be696c6d4b32 | Q1 | WALGREEN COMPANY | 309071 | WALGREEN COMPANY | 2011 | first_quarter | PHA | Drug safety-no specific legislation-regarding any discussions surrounding the security of the drug supply chain. | HOUSE OF REPRESENTATIVES,SENATE | 530000 | 0 | 0 | 2011-04-19T15:09:35.227000-04:00 | |
| 1086815 | MASSACHUSETTS MEDICAL SOCIETY cb8f4d3a-eae2-4dcf-8488-88da1ab6a028 | Q1 | MASSACHUSETTS MEDICAL SOCIETY | 23975 | MASSACHUSETTS MEDICAL SOCIETY | 2011 | first_quarter | PHA | CMS: Open Door Forum Comments on Transparency Reports and Reporting of Physician Ownership or Investment Issues | Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE | 90000 | 0 | 0 | 2011-04-19T15:12:52.757000-04:00 | |
| 1087177 | BROWN RUDNICK LLP 7bed8248-ed8a-4b8d-b62c-11d08d4affb9 | Q1 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2011 | first_quarter | PHA | Issues related to supply chain safety and drug theft; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 - Pill Mill Crackdown Act of 2011; S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011; S. 296 - Preserving Access to Life-Saving Medication Act of 2011 | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-19T15:41:34.790000-04:00 | |
| 1087201 | THORN RUN PARTNERS e704e8f7-e7b0-48a6-a7f8-883775fd16ec | Q1 | THORN RUN PARTNERS | 400534596 | LONG TERM CARE PHARMACY ALLIANCE | 2011 | first_quarter | PHA | Issues related to the implementation of the Affordable Care Act (ACA). Issues related to DEA enforcement of controlled substances in nursing homes. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-19T15:43:44.913000-04:00 | |
| 1087473 | 340B HEALTH ba471477-44e4-4c6c-b844-61c719c7113f | Q1 | 340B HEALTH | 316434 | 340B HEALTH | 2011 | first_quarter | PHA | Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 218868 | 0 | 0 | 2011-04-19T16:05:48.770000-04:00 | |
| 1087912 | GREATER NEW YORK HOSPITAL ASSOCIATION 159f4423-405e-40d7-b9d9-9cf349daf94a | Q1 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2011 | first_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296), and preserving access to group purchasing organizations. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 380000 | 0 | 0 | 2011-04-19T16:41:48.310000-04:00 | |
| 1088781 | BATES CAPITOL GROUP, INC. 53bcf7be-8449-488a-aeec-8c62141b73f9 | Q1 | BATES CAPITOL GROUP, INC. | 400656969 | C2 GROUP (ON BEHALF OF BIOTECHNOLOGY INDUSTRY ORGANIZATION) | 2011 | first_quarter | PHA | Support strong and fully funded FDA review process. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-19T18:23:03.623000-04:00 | |
| 1088959 | PODESTA GROUP, INC. d5c1beca-b7b5-4735-87d5-f3d2c9c6fda0 | Q1 | PODESTA GROUP, INC. | 31680 | AMGEN | 2011 | first_quarter | PHA | Prescription Drug User Fee Act reauthorization. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-04-19T19:05:40.837000-04:00 | |
| 1089078 | PODESTA GROUP, INC. af9e0e98-fe47-47e9-93f2-d325b86be1d6 | Q1 | PODESTA GROUP, INC. | 31680 | COVIDIEN | 2011 | first_quarter | PHA | Issues involving controlled substances and pain and addiction drugs generally. Issues related to acetaminophen. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-19T19:28:34.357000-04:00 | |
| 1089120 | PODESTA GROUP, INC. 96c6cbad-5bf5-4546-8f13-96321b701220 | Q1 | PODESTA GROUP, INC. | 31680 | EISAI INC. | 2011 | first_quarter | PHA | Drug issues, generally. Prescription Drug User Fee Act reauthorization. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-04-19T19:42:51.977000-04:00 | |
| 1089132 | WINSTON & STRAWN LLP ddf3373f-3b0e-41dd-8528-8089053de2d5 | Q1 | WINSTON & STRAWN LLP | 41682 | FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) | 2011 | first_quarter | PHA | Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters, including settlements. Legislation of interest includes the FY 2011 Financial Services Appropriations Bill (S. 3677), the FY 2010 Supplemental Appropriations Bill (H.R. 4899; P.L. 111-212), and the Continuing Appropriations and Surface Transportation Extensions Act, 2011 (H.R. 3082; P.L. 111-322). | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-04-19T19:48:59.320000-04:00 | ||
| 1089204 | DLA PIPER LLP (US) 5798c4ff-eaaf-4276-bb01-872ea147f90b | Q1 | DLA PIPER LLP (US) | 76855 | SANOFI PASTEUR | 2011 | first_quarter | PHA | Pandemic influenza, vaccine-related issues. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-04-19T20:15:45.150000-04:00 | |
| 1089245 | PODESTA GROUP, INC. ebd8976a-7475-4ec9-8691-99fd5037480e | Q1 | PODESTA GROUP, INC. | 31680 | NOVO NORDISK INC | 2011 | first_quarter | PHA | Prescription Drug User Fee Act reauthorization. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-04-19T20:30:05.260000-04:00 | |
| 1089251 | WINSTON & STRAWN LLP a08338f0-d47e-499e-b1e4-40049e8af3bc | Q1 | WINSTON & STRAWN LLP | 41682 | WOCKHARDT USA LLC | 2011 | first_quarter | PHA | Generic drug issues - preemption; FTC settlements | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-04-19T20:34:07.900000-04:00 | |
| 1089342 | THE INGRAM GROUP LLC 329aeb87-bb45-45e7-8b9f-aa038de318b7 | Q1 | THE INGRAM GROUP LLC | 400577737 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2011 | first_quarter | PHA | Issues related to the Patient Protection and Affordable Care Act: Medicare payment issues including the Independent Payment Advisory Board (IPAB) and S.23, Patent Reform Act of 2011. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-04-19T21:02:54.710000-04:00 | |
| 1089428 | WALMART INC. dc908053-d8cd-49e4-9cea-97f2a9cb79e3 | Q1 | WALMART INC. | 40305 | WALMART INC | 2011 | first_quarter | PHA | Discussions regarding generic drugs (no bill) | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Federal Trade Commission (FTC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Securities & Exchange Commission (SEC),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR),White House Office | 2390000 | 0 | 0 | 2011-04-19T21:31:34.820000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);